The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions (NCT06352047) | Clinical Trial Compass
CompletedNot Applicable
The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions
Turkey (Türkiye)42 participantsStarted 2018-11-01
Plain-language summary
The aim of this study was to examine the effect of positioning on respiratory functions of preterm infants after extubation.
Hypothesis 0a (H0a): There is no difference between the oxygen saturation (SpO2) levels of preterm infants in supine and prone positions after extubation.
Hypothesis 0b (H0b): There is no difference between the respiratory rate of preterm infants in supine and prone positions after extubation.
Hypothesis 0c (H0c): There is no difference between the respiratory rhythms of preterm infants in supine and prone positions after extubation.
Hypothesis 0d (H0d): There is no difference between respiratory distress in preterm infants in supine and prone positions after extubation.
Who can participate
Age range
37 Weeks – 37 Weeks
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Endotracheal intubation was applied,
* Those whose gestational weeks are under 37+6 years of age,
* Parts of premature babies whose parents gave written consent to participate were included.
Exclusion Criteria:
* Developing pneumothorax,
* Those with congenital anomalies,
* Those with intracranial hemorrhage and/or periventricular leukomalacia,
* Surgery that may affect heart, circulation and respiratory functions or prevent supine/prone positioning,
* Not intubated,
* Premature babies whose parents gave up participating in the study were not included in the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.